BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goshima S, Kanematsu M, Matsuo M, Kondo H, Kato H, Yokoyama R, Hoshi H, Moriyama N. Nodule-in-nodule appearance of hepatocellular carcinomas: comparison of gadolinium-enhanced and ferumoxides-enhanced magnetic resonance imaging. J Magn Reson Imaging. 2004;20:250-255. [PMID: 15269950 DOI: 10.1002/jmri.20100] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Hanna RF, Aguirre DA, Kased N, Emery SC, Peterson MR, Sirlin CB. Cirrhosis-associated Hepatocellular Nodules: Correlation of Histopathologic and MR Imaging Features. RadioGraphics 2008;28:747-69. [DOI: 10.1148/rg.283055108] [Cited by in Crossref: 130] [Cited by in F6Publishing: 93] [Article Influence: 9.3] [Reference Citation Analysis]
2 Barr DC, Hussain HK. Magnetic Resonance Imaging in Cirrhosis: What’s New? Topics in Magnetic Resonance Imaging 2014;23:129-49. [DOI: 10.1097/rmr.0000000000000017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Cannella R, Calandra A, Cabibbo G, Midiri M, Tang A, Brancatelli G. Hyperintense nodule-in-nodule on hepatobiliary phase arising within hypovascular hypointense nodule: Outcome and rate of hypervascular transformation. European Journal of Radiology 2019;120:108689. [DOI: 10.1016/j.ejrad.2019.108689] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Yu ZJ, Yu JW, Cai W, Yuan HX, Li XY, Yuan Y, Chen JP, Wu XY, Yao DF. Evaluation of HCPTd1, d14-double passaged intervening chemotherapy protocol for hepatocellular carcinoma. World J Gastroenterol 2005; 11(33): 5221-5225 [PMID: 16127757 DOI: 10.3748/wjg.v11.i33.5221] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Ishigami K, Tajima T, Fujita N, Nishie A, Asayama Y, Kakihara D, Nakayama T, Okamoto D, Taketomi A, Shirabe K, Honda H. Hepatocellular carcinoma with marginal superparamagnetic iron oxide uptake on T2*-weighted magnetic resonance imaging: histopathologic correlation. Eur J Radiol 2011;80:e293-8. [PMID: 21288675 DOI: 10.1016/j.ejrad.2010.12.078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Willatt JM, Hussain HK, Adusumilli S, Marrero JA. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology. 2008;247:311-330. [PMID: 18430871 DOI: 10.1148/radiol.2472061331] [Cited by in Crossref: 274] [Cited by in F6Publishing: 233] [Article Influence: 19.6] [Reference Citation Analysis]
7 Ba-Ssalamah A, Fakhrai N, Matzek WK, Herneth AM, Stadler A, Bastati N, Herold CJ, Schima W. Magnetic resonance imaging of liver malignancies. Top Magn Reson Imaging 2007;18:445-55. [PMID: 18303402 DOI: 10.1097/rmr.0b013e3181614374] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
8 Suh YJ, Kim M, Choi J, Park YN, Park M, Kim KW. Differentiation of Hepatic Hyperintense Lesions Seen on Gadoxetic Acid–Enhanced Hepatobiliary Phase MRI. American Journal of Roentgenology 2011;197:W44-52. [DOI: 10.2214/ajr.10.5845] [Cited by in Crossref: 62] [Cited by in F6Publishing: 19] [Article Influence: 5.6] [Reference Citation Analysis]
9 Park YS, Lee CH, Kim JW, Shin S, Park CM. Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents? World J Gastroenterol 2016; 22(1): 284-299 [PMID: 26755877 DOI: 10.3748/wjg.v22.i1.284] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
10 Tonan T, Fujimoto K, Qayyum A. Chronic hepatitis and cirrhosis on MR imaging. Magn Reson Imaging Clin N Am 2010;18:383-402, ix. [PMID: 21094446 DOI: 10.1016/j.mric.2010.08.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
11 Shinmura R, Matsui O, Kadoya M, Kobayashi S, Terayama N, Sanada J, Demachi H, Gabata T. Detection of hypervascular malignant foci in borderline lesions of hepatocellular carcinoma: comparison of dynamic multi-detector row CT, dynamic MR imaging and superparamagnetic iron oxide-enhanced MR imaging. Eur Radiol 2008;18:1918-24. [PMID: 18386012 DOI: 10.1007/s00330-008-0954-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
12 Kloth C, Vogele D, Brunner H, Beer M, Schmidt SA. Pathognomonic imaging signs in abdominal radiology. Abdom Radiol (NY) 2020;45:576-86. [PMID: 31834459 DOI: 10.1007/s00261-019-02331-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
13 Watanabe A, Ramalho M, AlObaidy M, Kim HJ, Velloni FG, Semelka RC. Magnetic resonance imaging of the cirrhotic liver: An update. World J Hepatol 2015; 7(3): 468-487 [PMID: 25848471 DOI: 10.4254/wjh.v7.i3.468] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
14 Kadoury S, Yan P, Xu S, Glossop N, Choyke P, Turkbey B, Pinto P, Wood BJ, Kruecker J. Realtime TRUS/MRI Fusion Targeted-Biopsy for Prostate Cancer: A Clinical Demonstration of Increased Positive Biopsy Rates. In: Madabhushi A, Dowling J, Yan P, Fenster A, Abolmaesumi P, Hata N, editors. Prostate Cancer Imaging. Computer-Aided Diagnosis, Prognosis, and Intervention. Berlin: Springer Berlin Heidelberg; 2010. pp. 52-62. [DOI: 10.1007/978-3-642-15989-3_7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]